Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosisMarc Gurun, Christopher J. Byrne, Damien Leith et al.|PLoS ONE|2024Cited by 29